SCHEMBL16848641

SCHEMBL16848641

N#Cc1c(F)cc(-c2c(F)cc(-c3ccc(OC(=O)CCCCCC(=O)Oc4ccc(-c5ccc(F)cc5)c(F)c4)cc3)cc2F)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ SQOR Q9Y6N5 1/20 0.33
▸ PDE10A Q9Y233 2/20 0.33
▸ HDAC1 Q13547 2/20 0.33
▸ HDAC2 Q92769 2/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ HDAC7 Q8WUI4 1/20 0.33
▸ HDAC10 Q969S8 1/20 0.33
▸ HDAC11 Q96DB2 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ HDAC9 Q9UKV0 1/20 0.33
▸ HDAC5 Q9UQL6 1/20 0.33
▸ APP P05067 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16748095 1.00 KMT2A (0.40) KMT2AALDH1A1HSD17B10SMN1; SMN2KDM4E
SCHEMBL16748083 1.00 KMT2A (0.40) KMT2AALDH1A1HSD17B10SMN1; SMN2KDM4E
SCHEMBL18118875 0.96 KMT2A (0.39) KMT2AALDH1A1HSD17B10SMN1; SMN2KDM4E
SCHEMBL19078858 0.96 KMT2A (0.40) KMT2AALDH1A1HSD17B10SMN1; SMN2KDM4E
SCHEMBL19078857 0.96 KMT2A (0.40) KMT2AALDH1A1HSD17B10SMN1; SMN2KDM4E
SCHEMBL19078856 0.96 KMT2A (0.40) KMT2AALDH1A1HSD17B10SMN1; SMN2KDM4E
SCHEMBL18785350 0.96 KMT2A (0.40) KMT2AALDH1A1HSD17B10SMN1; SMN2KDM4E
SCHEMBL21676960 0.94 KMT2A (0.37) KMT2AALDH1A1HSD17B10SMN1; SMN2KDM4E
SCHEMBL22383792 0.94 KMT2A (0.37) KMT2AALDH1A1HSD17B10SMN1; SMN2KDM4E
SCHEMBL18118870 0.93 HDAC1 (0.40) KMT2AALDH1A1HSD17B10KDM4EHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512920-B1 LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DEVICE MERCK PATENT GMBH (DE) 2020-11-04 — — EP disclosed
EP-3248060-B1 LIGHT MODULATION ELEMENT MERCK PATENT GMBH (DE) 2020-09-02 — — EP disclosed
EP-3365411-B1 LIGHT MODULATION ELEMENT MERCK PATENT GMBH (DE) 2020-05-13 — — EP disclosed
EP-3215892-B1 LIGHT MODULATION ELEMENT MERCK PATENT GMBH (DE) 2020-03-18 — — EP disclosed
EP-3071668-B1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2018-07-18 — — EP disclosed
EP-3167025-B1 MESOGENIC MEDIA AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2018-07-18 — — EP disclosed
US-20180187081-A1 PROCESS OF PREPARING A LIGHT MODULATION ELEMENT MERCK PATENT GMBH (DE) 2018-07-05 — — US disclosed
US-20180188586-A1 PROCESS OF PREPARING A LIGHT MODULATION ELEMENT MERCK PATENT GMBH (DE) 2018-07-05 — — US disclosed
EP-3071669-B1 MESOGENIC MEDIA AND LIQUID CRYSTAL DISPLAY DEVICE MERCK PATENT GMBH (DE) 2018-06-20 — — EP disclosed
US-20180016499-A1 LIGHT MODULATION ELEMENT MERCK PATENT GMBH (DE) 2018-01-18 — — US disclosed
US-20180004045-A1 LIGHT MODULATION ELEMENT MERCK PATENT GMBH (DE) 2018-01-04 — — US disclosed
US-20170357131-A1 LIGHT MODULATION ELEMENT MERCK PATENT GMBH (DE) 2017-12-14 — — US disclosed
US-20170351130-A1 LIGHT MODULATION ELEMENT MERCK PATENT GMBH (DE) 2017-12-07 — — US disclosed
US-20170343847-A1 LIGHT MODULATION ELEMENT MERCK PATENT GMBH (DE) 2017-11-30 — — US disclosed
EP-2855631-B1 MESOGENIC MEDIA AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2017-09-20 — — EP disclosed
US-9752075-B2 Mesogenic media and liquid crystal display MERCK PATENT GMBH (DE) 2017-09-05 — — US disclosed
US-20170190971-A1 MESOGENIC MEDIA AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2017-07-06 — — US disclosed
US-20160298031-A1 MESOGENIC MEDIA AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2016-10-13 — — US disclosed
US-20160289561-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA MERCK PATENT GMBH (DE) 2016-10-06 — — US disclosed
US-20150175886-A1 MESOGENIC MEDIA AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2015-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160289561-A1 BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA SP1, FOXM1, S100A11 KMT2A 2044/4885ALDH1A1 4548/4885HSD17B10 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback